Tci Wealth Advisors, Inc. Novo Nordisk A S Transaction History

Tci Wealth Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$132.34 - $159.14 $12,704 - $15,277	-96 Reduced 69.06%	43 $6,000
Q4 2022 Feb 06, 2023	BUY	$102.55 - $135.33 $7,896 - $10,420	77 Added 124.19%	139 $18,000
Q3 2022 Nov 08, 2022	SELL	$95.28 - $116.93 $381 - $467	-4 Reduced 6.06%	62 $6,000
Q2 2022 Jul 19, 2022	SELL	$103.24 - $121.81 $929 - $1,096	-9 Reduced 12.0%	66 $7,000
Q1 2021 Apr 29, 2021	SELL	$67.06 - $75.82 $12,406 - $14,026	-185 Reduced 71.15%	75 $5,000
Q4 2020 Jan 21, 2021	SELL	$63.89 - $73.8 $255 - $295	-4 Reduced 1.52%	260 $18,000
Q3 2020 Oct 20, 2020	SELL	$63.69 - $70.22 $3,311 - $3,651	-52 Reduced 16.46%	264 $18,000
Q2 2020 Jul 20, 2020	BUY	$58.54 - $67.94 $18,498 - $21,469	316 New	316 $21,000
Q1 2020 Apr 14, 2020	SELL	$49.46 - $64.78 $4,550 - $5,959	-92 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$49.86 - $58.26 $4,587 - $5,359	92 New	92 $5,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.